Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia
Clinical trial NCT01013961 · TERMINATED
Trial details
- NCT number
- NCT01013961
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-27
- Primary completion
- 2015-04-14
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.